New report finds that just 13% of IP-owning firms have sought financing through their assets, with billions in potential ...
10 April 2026 The 2026 panel has been chosen. With judges from Amgen, Pfizer, Eli Lilly, Takeda, Regeneron and law firms such ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results